Rationale for IL-37 as a novel therapeutic agent in inflammation

Claudia A. Nold-Petry; Marcel F. Nold

doi:10.1080/1744666X.2022.2108792

Rationale for IL-37 as a novel therapeutic agent in inflammation

Paediatrics Monash Health

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	1203-1206
Number of pages	4
Journal	Expert Review of Clinical Immunology
Volume	18
Issue number	12
DOIs	https://doi.org/10.1080/1744666X.2022.2108792
Publication status	Published - 2 Dec 2022

Keywords

Acute inflammation
anti-inflammatory treatment
chronic inflammation
cytokine
disease mechanisms
immunology
interleukin 37
novel therapeutic
translational research

Access to Document

10.1080/1744666X.2022.2108792

Cite this

@article{8a45244f52054aef95ae624bb630666a,

title = "Rationale for IL-37 as a novel therapeutic agent in inflammation",

keywords = "Acute inflammation, anti-inflammatory treatment, chronic inflammation, cytokine, disease mechanisms, immunology, interleukin 37, novel therapeutic, translational research",

author = "Nold-Petry, \{Claudia A.\} and Nold, \{Marcel F.\}",

note = "Funding Information: This work was supported by the National Health and Medical Research Council Investigator Grant Leadership 1 APP1173584 to C A Nold-Petry, and by the Fielding Foundation{\textquoteright}s Innovation Award and Fellowship to M F Nold.",

year = "2022",

month = dec,

day = "2",

doi = "10.1080/1744666X.2022.2108792",

language = "English",

volume = "18",

pages = "1203--1206",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Taylor \& Francis",

number = "12",

}

TY - JOUR

T1 - Rationale for IL-37 as a novel therapeutic agent in inflammation

AU - Nold-Petry, Claudia A.

AU - Nold, Marcel F.

N1 - Funding Information: This work was supported by the National Health and Medical Research Council Investigator Grant Leadership 1 APP1173584 to C A Nold-Petry, and by the Fielding Foundation’s Innovation Award and Fellowship to M F Nold.

PY - 2022/12/2

Y1 - 2022/12/2

KW - Acute inflammation

KW - anti-inflammatory treatment

KW - chronic inflammation

KW - cytokine

KW - disease mechanisms

KW - immunology

KW - interleukin 37

KW - novel therapeutic

KW - translational research

UR - https://www.scopus.com/pages/publications/85136111595

U2 - 10.1080/1744666X.2022.2108792

DO - 10.1080/1744666X.2022.2108792

M3 - Editorial

C2 - 35916240

AN - SCOPUS:85136111595

SN - 1744-666X

VL - 18

SP - 1203

EP - 1206

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

IS - 12

ER -

Rationale for IL-37 as a novel therapeutic agent in inflammation

Keywords

Access to Document

Other files and links

Interventional Immunology in Early Life Diseases

Cite this

Rationale for IL-37 as a novel therapeutic agent in inflammation

Keywords

Access to Document

Other files and links

Projects

Interventional Immunology in Early Life Diseases

Cite this